The General Movement Optimality Score-Revised (GMOS-R) with Socioeconomically Stratified Percentile Ranks.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE

Original Publication: Basel, Switzerland : MDPI AG, [2012]-

Background: The general movement optimality score (GMOS) quantifies the details of general movements (GMs). We recently conducted psychometric analyses of the GMOS and developed a revised scoresheet. Consequently, the GMOS-Revised (GMOS-R) instrument necessitated validation using new percentile ranks. This study aimed to provide these percentile ranks for the GMOS-R and to investigate whether sex, preterm birth, or the infant's country of birth and residence affected the GMOS-R distribution. Methods: We applied the GMOS-R to an international sample of 1983 infants (32% female, 44% male, and 24% not disclosed), assessed in the extremely and very preterm period (10%), moderate (12%) and late (22%) preterm periods, at term (25%), and post-term age (31%). Data were grouped according to the World Bank's classification into lower- and upper-middle-income countries (LMICs and UMICs; 26%) or high-income countries (HICs; 74%), respectively. Results: We found that sex and preterm or term birth did not affect either GM classification or the GMOS-R, but the country of residence did. A lower median GMOS-R for infants with normal or poor-repertoire GMs from LMICs and UMICs compared with HICs suggests the use of specific percentile ranks for LMICs and UMICs vs. HICs. Conclusion: For clinical and scientific use, we provide a freely available GMOS-R scoring sheet, with percentile ranks reflecting socioeconomic stratification.

Phys Occup Ther Pediatr. 2018 Aug;38(3):269-279. (PMID: 29144840)
Early Hum Dev. 2016 Aug;99:37-41. (PMID: 27390110)
J Dev Phys Disabil. 2020;32(4):587-598. (PMID: 32669775)
Nat Rev Neurol. 2023 Mar;19(3):136-159. (PMID: 36747038)
Rev Saude Publica. 2018 Feb 05;52:6. (PMID: 29412374)
Pediatr Phys Ther. 2017 Oct;29(4):315-320. (PMID: 28953174)
Pediatr Res. 2012 Jan;71(1):100-6. (PMID: 22289857)
Int J Environ Res Public Health. 2022 Aug 24;19(17):. (PMID: 36078258)
iScience. 2023 Mar 07;26(4):106348. (PMID: 36994082)
Early Hum Dev. 1990 Sep;23(3):159-91. (PMID: 2253579)
J Appl Meas. 2020;21(1):17-37. (PMID: 32129767)
Neonatology. 2021;118(5):593-599. (PMID: 34515185)
J Perinatol. 2018 Nov;38(11):1518-1525. (PMID: 30177861)
Sci Rep. 2021 May 10;11(1):9888. (PMID: 33972661)
BMJ Open. 2021 Mar 4;11(3):e042147. (PMID: 33664072)
Res Dev Disabil. 2021 Mar;110:103854. (PMID: 33571849)
JAMA Netw Open. 2019 Jan 4;2(1):e187235. (PMID: 30657537)
Early Hum Dev. 1990 Sep;23(3):193-231. (PMID: 2253580)
Early Hum Dev. 1997 Nov 24;50(1):47-60. (PMID: 9467693)
Dev Med Child Neurol. 2016 Apr;58(4):361-8. (PMID: 26365130)
J Affect Disord. 2020 May 1;268:158-172. (PMID: 32174474)
Brain Dev. 2015 Apr;37(4):387-93. (PMID: 25052783)
Lancet Glob Health. 2019 Jan;7(1):e37-e46. (PMID: 30389451)
Lancet. 1997 May 10;349(9062):1361-3. (PMID: 9149699)
Early Hum Dev. 2010 Apr;86(4):225-9. (PMID: 20488635)
Early Hum Dev. 2021 Dec;163:105452. (PMID: 34543944)
PLoS One. 2013 May 28;8(5):e64654. (PMID: 23785389)
Early Hum Dev. 2019 Jul;134:1-6. (PMID: 31063888)
Commun Med (Lond). 2023 Aug 16;3(1):112. (PMID: 37587165)
BMC Complement Altern Med. 2016 Jan 13;16:12. (PMID: 26758035)
Early Hum Dev. 2017 Jul;110:13-15. (PMID: 28472725)
Sensors (Basel). 2020 Sep 17;20(18):. (PMID: 32957598)
Early Hum Dev. 2021 Oct;161:105449. (PMID: 34481188)
BMJ Open. 2016 Oct 3;6(10):e013446. (PMID: 27697883)
Syst Rev. 2021 Aug 12;10(1):226. (PMID: 34384482)
J Pediatr Gastroenterol Nutr. 2021 Apr 1;72(4):592-596. (PMID: 33346571)
Early Hum Dev. 1980 Sep;4(3):201-5. (PMID: 7418634)
BMJ Open. 2023 Jan 23;13(1):e069194. (PMID: 36690405)
Early Hum Dev. 2015 Dec;91(12):683-8. (PMID: 26513629)
BMJ Open. 2020 Nov 3;10(11):e037335. (PMID: 33148727)
JAMA Pediatr. 2022 Aug 1;176(8):787-796. (PMID: 35639401)
Early Hum Dev. 2021 Dec;163:105488. (PMID: 34695679)
Curr Neurol Neurosci Rep. 2017 May;17(5):43. (PMID: 28390033)
JAMA Pediatr. 2017 Sep 1;171(9):897-907. (PMID: 28715518)
Early Hum Dev. 1990 Sep;23(3):151-8. (PMID: 2253578)
Int J Environ Res Public Health. 2021 Jun 18;18(12):. (PMID: 34207310)
Brain Dev. 2019 Jun;41(6):490-500. (PMID: 30770148)
Pediatr Neonatol. 2022 Sep;63(5):535-541. (PMID: 35965235)
Pediatr Phys Ther. 2021 Oct 1;33(4):208-216. (PMID: 34618744)
Semin Perinatol. 2019 Aug;43(5):297-307. (PMID: 31005357)
Brain Dev. 2021 Mar;43(3):363-371. (PMID: 33239233)
Semin Fetal Neonatal Med. 2021 Oct;26(5):101271. (PMID: 34330679)
Early Hum Dev. 2021 Dec;163:105484. (PMID: 34655917)
J Clin Med. 2021 Mar 04;10(5):. (PMID: 33806626)
Acta Paediatr. 2021 Aug;110(8):2350-2351. (PMID: 33811376)
JAMA Netw Open. 2022 Jul 1;5(7):e2221325. (PMID: 35816301)
PLoS One. 2021 Aug 5;16(8):e0255352. (PMID: 34352883)
Early Hum Dev. 2016 Oct;101:63-8. (PMID: 27411107)

OPP 1128871 United States GATES Bill & Melinda Gates Foundation; KL2TR001424 United States TR NCATS NIH HHS

Keywords: World Bank data; general movements; optimality score; preterm; sex; term

Date Created: 20240427 Latest Revision: 20240429

20240429

PMC11050782

10.3390/jcm13082260

38673533